Dr. Mary T. Pronovost, MD

Dr. Pronovost practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Pronovost's NPI, 1851350011, was assigned on March 17, 2006. Dr. Pronovost graduated from Temple University School of Medicine in 1991. Dr. Pronovost holds Connecticut license 037703.

Dr. Pronovost's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Pronovost's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Pronovost is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians. Dmand AI also links Dr. Pronovost to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pronovost practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Pronovost's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Pronovost is licensed in Connecticut.

CMS data shows 117 Medicare services from Dr. Pronovost across 5 procedure codes in 2024, for 82 Medicare patients. Medicare paid $17,597 for them.

CMS counts 82 Medicare patients who saw Dr. Pronovost in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high cholesterol, and 74% have cancer. 35% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pronovost's median patient age at 67, with 97% women.

In 2024, Dr. Pronovost wrote 50 Medicare Part D claims for 37 patients. 100% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $19 in total drug cost. In 2021, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Pronovost for performance year 2024, reported as part of a group. Dr. Pronovost accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of mastectomy by Dr. Pronovost, more than 91% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Pronovost, published from 2018 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Breast Neoplasms, Breast Implantation and Breast Implants. Dr. Pronovost has published most often in Ann Surg Oncol. Dr. Pronovost's most frequent co-authors are Austin David Williams, MD, Allison A. Aggon, DO and Richard J. Bleicher, MD.

CMS Open Payments shows 8 general payments to Dr. Pronovost from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Elucent Medical paid the most, $367.

Dr. Pronovost graduated from Temple University School of Medicine in 1991.